Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 280

Results For "ET"

10737 News Found

CPHIA 2026 to advance Africa’s health security and resilience
Public Health | May 11, 2026

CPHIA 2026 to advance Africa’s health security and resilience

The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners


Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala
Hospitals | May 11, 2026

Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala

Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India


Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million
News | May 11, 2026

Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million

Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint


Experts push for patient-centric healthcare at IHW Patient First Summit 2026
Healthcare | May 11, 2026

Experts push for patient-centric healthcare at IHW Patient First Summit 2026

Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care


Sebia India and CAHO launch autoimmunity masterclass series
Healthcare | May 11, 2026

Sebia India and CAHO launch autoimmunity masterclass series

The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases


Dr. Jitendra Singh calls for stronger research ecosystem
Policy | May 11, 2026

Dr. Jitendra Singh calls for stronger research ecosystem

The Union Minister reviewed DST-supported SATHI-BHU facility


Over 3,500 participate in NHA's  AI hackathon
Digitisation | May 11, 2026

Over 3,500 participate in NHA's AI hackathon

Initiative by National Health Authority aimed at accelerating automated claims processing under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana


Bristol Myers Squibb wins EU nod for Sotyktu in active psoriatic arthritis
Drug Approval | May 11, 2026

Bristol Myers Squibb wins EU nod for Sotyktu in active psoriatic arthritis

The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio


Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth
People | May 11, 2026

Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth

Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector